RNA respiratory viruses are a significant cause of morbidity and mortality in solid organ transplant recipients.
Heightens vigilance for respiratory viruses in transplant recipients; leaves open optimal prevention strategies pending prospective trials.
A wide range of RNA respiratory viruses have been identified as causes of significant morbidity and mortality among transplant recipients, including influenza, respiratory syncytial virus (RSV), parainfluenza virus (PIV), rhinovirus, human metapneumovirus (hMPV), coronavirus, bocavirus and polyomaviruses (1) (Table 1). Several features are common among all of these viruses in the transplant population:
No takes yet. Share an insight, caveat, or question.
Ison et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: